start portlet menu bar end portlet menu bar

Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response)

Home Knowledge Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response)

Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response)

The aim of this study is evaluate the efcacy of a new S . uberis vaccine against bovine mastitis (UBAC®, HIPRA S.A, Spain) after an experimental intramammary challenge with a heterologous S . uberis strain (SU2H) in dairy heifers.

Download this article

140 KB

About this article

Appeared in

National Mastitis Council, 2018

Date

Jun 11, 2018

Authors

Montbrau, C.; Collado, R.; Prenafeta, A.; March, R.; Moreno, J.

Summary

The results presented in this study demonstrate that the intramuscular immunization of dairy heifers with UBAC® vaccine signicantly reduces the bacteriological count and SCC, increasing the cure rate of the infected quarters after an intramammary infection with S . uberis heterologous strain.

Related products

UBAC®

Related publications

Immune response of dairy cows following vaccination with UBAC® in a clinical trial A diagnostic tool for the detection and quantification of pathogenic bacteria in bovine milk samples from dairy farms in South Korea Case Report: Field experience with a polyvalent mastitis vaccine on a commercial dairy farm infected with Klebsiella

Share this on

start portlet menu bar

UBAC® vaccine against intramammary heterologous challenge in dairy heifers

Display portlet menu
end portlet menu bar

See also

Publications

Immune response of dairy cows following vaccination with UBAC® in a clinical trial

13-06-2019
Disease Summaries

IBR AGAINST THE ROPES

21-10-2019
News

HIPRA presents INMEVA, the new inactivated vaccine against abortions caused by Chlamydia a...

12-09-2019